Clinical significance of non clinical end-points in studies on the prevention of venous thromboembolism.
Agnelli
G
G
Istituto di Medicina Interna e Medicina Vascolare, Università di Perugia, Italy. agnellig@unipg.it
D002986:Clinical Trials as Topic / Q000379:methods*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010690:Phlebography; D012680:Sensitivity and Specificity; D013923:Thromboembolism / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000517:prevention & control*; D016896:Treatment Outcome; D014463:Ultrasonography / Q000379:methods; D020246:Venous Thrombosis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000517:prevention & control
D005343:Fibrinolytic Agents